The Infectious Diseases Society of America Emerging Infections Network: Bridging the Gap Between Clinical Infectious Diseases and Public Health

Pillai, Satish K.; Beekmann, Susan E.; Santibañez, Scott; Polgreen, Philip M.

doi:10.1093/cid/cit932

Cited by 57 publications

(53 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Infectious Diseases Society of America's Emerging Infections Network (EIN) is a provider-based network of practicing infectious disease (ID) specialists in the United States and Canada, funded by the Centers for Disease Control and Prevention [6]. With input from a subset of experienced EIN members, we developed a 7-question multiple-choice query to assess ID specialist practice patterns related to the management of CIED infections based on commonly encountered clinical scenarios (Supplementary Material).…”

Section: Methodsmentioning

confidence: 99%

“…This query was distributed by e-mail or facsimile with 2 weekly reminders. Our query process and EIN members are described elsewhere [6].Nonresponse bias was assessed by comparing geographic and practice characteristics of nonrespondents and respondents. Respondents who had treated 1 or more CIED infections in the past year were included in further analyses, and respondents were not required to answer all questions.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Current Management of Cardiac Implantable Electronic Device Infections by Infectious Disease Specialists

et al. 2016

View full text Add to dashboard Cite

Management guidelines for cardiac implantable electronic device infections exist, but practice patterns of infectious disease (ID) specialists are not well known. We found that while many ID specialist practices mirror existing guidelines, a combination of complete device removal and prolonged antimicrobial therapy is favored when Staphylococcus aureus is involved.Keywords. device-related infection; cardiac implantable electronic device; infectious disease specialists.Cardiac implantable electronic devices (CIEDs) including percutaneous pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy devices have revolutionized the management of arrhythmias and congestive heart failure. However, infections can complicate the use of these devices, with rates ranging from <1% to 4% [1][2][3][4]. Guidelines for treatment of CIED infections exist [5], but little is known about current practice patterns for these challenging infections. METHODSThe Infectious Diseases Society of America's Emerging Infections Network (EIN) is a provider-based network of practicing infectious disease (ID) specialists in the United States and Canada, funded by the Centers for Disease Control and Prevention [6]. With input from a subset of experienced EIN members, we developed a 7-question multiple-choice query to assess ID specialist practice patterns related to the management of CIED infections based on commonly encountered clinical scenarios (Supplementary Material). This query was distributed by e-mail or facsimile with 2 weekly reminders. Our query process and EIN members are described elsewhere [6].Nonresponse bias was assessed by comparing geographic and practice characteristics of nonrespondents and respondents. Respondents who had treated 1 or more CIED infections in the past year were included in further analyses, and respondents were not required to answer all questions. Categorical variables were compared using a χ 2 test or Fisher exact test with SAS, version 9.3 (Cary, North Carolina). P values <.05 were considered significant. RESULTSThe electronic query was available to EIN members from 29 Complete vs Partial Device RemovalWhen treating occult bacteremia in a patient with a CIED, 146/358 (46%) respondents preferred (ie, usually or almost always recommended) complete device removal. In contrast, only 25/345 (7%) preferred partial device removal. When bacteremia was attributable to a noncardiovascular infection (eg, pneumonia), fewer respondents (40/355; 11%) preferred complete device removal, and only 9/345 (3%) preferred partial device removal. For a patient with CIED-related pocket infection that required incision and drainage, most (293/359; 82%) preferred complete device removal; 102/347 (29%) also preferred partial device removal as an alternative. For lead-associated endocarditis, nearly all respondents (356/ 360; 99%) preferred complete device removal, whereas only 70/345 (20%) also preferred partial device removal as an alternative.Nearly three quarters (73%) of respondents endorsed comple...

show abstract

Section: Methodsmentioning

confidence: 99%

mentioning

confidence: 99%

Current Management of Cardiac Implantable Electronic Device Infections by Infectious Disease Specialists

et al. 2016

View full text Add to dashboard Cite

show abstract

“…The EIN is a provider-based emerging infections sentinel network funded by the Centers for Disease Control and Prevention to gather information about clinical aspects of infectious diseases (Pillai et al, 2014). An 11-question survey was distributed via e-mail or facsimile to 1287 EIN members who care for adult patients from the United States, Puerto Rico, and Canada in May 2013.…”

Section: Methodsmentioning

confidence: 99%

Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers

Harris

Beekmann

Polgreen

et al. 2014

Diagnostic Microbiology and Infectious Disease

View full text Add to dashboard Cite

Streptococcus pneumoniae (pneumococcus) is the most common bacterial etiology of community-acquired pneumonia (CAP) in adults, a leading cause of death. The majority of pneumococcal CAP is diagnosed by blood culture, which likely underestimates the burden of disease. The 2007 CAP guidelines recommend routine use of the rapid pneumococcal urinary antigen (UAg) test. To assess the how pneumococcal UAg testing is being used among hospitalized adult CAP patients and what barriers restrict its use, a Web-based survey was distributed in 2013 to 1287 infectious disease physician members of the Emerging Infectious disease Network of the Infectious Disease Society of America. Of 493 eligible responses, 65% use the pneumococcal UAg test. The primary barrier to UAg use was availability (46%). UAg users reported ordering fewer other diagnostic tests and tailoring antibiotic therapy. Increased access to UAg tests could improve pneumonia management and pneumococcal CAP surveillance.

show abstract

“…The EIN is a network of infectious diseases physicians in North America that was established in 1995 by the CDC to create a provider-based emerging infections sentinel network 3 . EIN members who receive surveys are physician members of IDSA who are actively involved in the practice of infectious diseases.…”

Section: Methodsmentioning

confidence: 99%

Unmet diagnostic needs in infectious disease

Blaschke

Hersh

Beekmann

et al. 2015

Diagnostic Microbiology and Infectious Disease

View full text Add to dashboard Cite

Accurate diagnosis is critical to providing appropriate care in infectious diseases. New technologies for infectious disease diagnostics are emerging, but gaps remain in test development and availability. The Emerging Infections Network surveyed Infectious Diseases physicians to assess unmet diagnostic needs. Responses reflected the urgent need to identify drug-resistant infections and highlighted the potential for early diagnosis to improve antibiotic stewardship. Information gained from this survey can help inform recommendations for new diagnostic test development in the future.

show abstract

The Infectious Diseases Society of America Emerging Infections Network: Bridging the Gap Between Clinical Infectious Diseases and Public Health

Cited by 57 publications

References 20 publications

Current Management of Cardiac Implantable Electronic Device Infections by Infectious Disease Specialists

Current Management of Cardiac Implantable Electronic Device Infections by Infectious Disease Specialists

Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers

Unmet diagnostic needs in infectious disease

Contact Info

Product

Resources

About